198 related articles for article (PubMed ID: 12654906)
1. Binding discrimination of MutS to a set of lesions and compound lesions (base damage and mismatch) reveals its potential role as a cisplatin-damaged DNA sensing protein.
Fourrier L; Brooks P; Malinge JM
J Biol Chem; 2003 Jun; 278(23):21267-75. PubMed ID: 12654906
[TBL] [Abstract][Full Text] [Related]
2. Modulation of MutS ATP-dependent functional activities by DNA containing a cisplatin compound lesion (base damage and mismatch).
Sedletska Y; Fourrier L; Malinge JM
J Mol Biol; 2007 May; 369(1):27-40. PubMed ID: 17400248
[TBL] [Abstract][Full Text] [Related]
3. Interaction studies of muts and mutl with DNA containing the major cisplatin lesion and its mismatched counterpart under equilibrium and nonequilibrium conditions.
Sedletska Y; Culard F; Midoux P; Malinge JM
Biopolymers; 2013 Sep; 99(9):636-47. PubMed ID: 23494597
[TBL] [Abstract][Full Text] [Related]
4. Human MutSalpha recognizes damaged DNA base pairs containing O6-methylguanine, O4-methylthymine, or the cisplatin-d(GpG) adduct.
Duckett DR; Drummond JT; Murchie AI; Reardon JT; Sancar A; Lilley DM; Modrich P
Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6443-7. PubMed ID: 8692834
[TBL] [Abstract][Full Text] [Related]
5. Enzymatic repair of 5-formyluracil. II. Mismatch formation between 5-formyluracil and guanine during dna replication and its recognition by two proteins involved in base excision repair (AlkA) and mismatch repair (MutS).
Terato H; Masaoka A; Kobayashi M; Fukushima S; Ohyama Y; Yoshida M; Ide H
J Biol Chem; 1999 Aug; 274(35):25144-50. PubMed ID: 10455196
[TBL] [Abstract][Full Text] [Related]
6. Recognition and repair of compound DNA lesions (base damage and mismatch) by human mismatch repair and excision repair systems.
Mu D; Tursun M; Duckett DR; Drummond JT; Modrich P; Sancar A
Mol Cell Biol; 1997 Feb; 17(2):760-9. PubMed ID: 9001230
[TBL] [Abstract][Full Text] [Related]
7. Competition between MutY and mismatch repair at A x C mispairs In vivo.
Kim M; Huang T; Miller JH
J Bacteriol; 2003 Aug; 185(15):4626-9. PubMed ID: 12867475
[TBL] [Abstract][Full Text] [Related]
8. MutS recognition of exocyclic DNA adducts that are endogenous products of lipid oxidation.
Johnson KA; Mierzwa ML; Fink SP; Marnett LJ
J Biol Chem; 1999 Sep; 274(38):27112-8. PubMed ID: 10480926
[TBL] [Abstract][Full Text] [Related]
9. Binding of MutS mismatch repair protein to DNA containing UV photoproducts, "mismatched" opposite Watson--Crick and novel nucleotides, in different DNA sequence contexts.
Hoffman PD; Wang H; Lawrence CW; Iwai S; Hanaoka F; Hays JB
DNA Repair (Amst); 2005 Aug; 4(9):983-93. PubMed ID: 15996534
[TBL] [Abstract][Full Text] [Related]
10. MutS preferentially recognizes cisplatin- over oxaliplatin-modified DNA.
Zdraveski ZZ; Mello JA; Farinelli CK; Essigmann JM; Marinus MG
J Biol Chem; 2002 Jan; 277(2):1255-60. PubMed ID: 11705991
[TBL] [Abstract][Full Text] [Related]
11. RNA polymerases react differently at d(ApG) and d(GpG) adducts in DNA modified by cis-diamminedichloroplatinum(II).
Corda Y; Anin MF; Leng M; Job D
Biochemistry; 1992 Feb; 31(7):1904-8. PubMed ID: 1536834
[TBL] [Abstract][Full Text] [Related]
12. Selective recognition of a cisplatin-DNA adduct by human mismatch repair proteins.
Yamada M; O'Regan E; Brown R; Karran P
Nucleic Acids Res; 1997 Feb; 25(3):491-6. PubMed ID: 9016586
[TBL] [Abstract][Full Text] [Related]
13. Escherichia coli RecA promotes strand invasion with cisplatin-damaged DNA.
Nimonkar AV; Le Gac NT; Villani G; Boehmer PE
Biochimie; 2006 May; 88(5):535-42. PubMed ID: 16376475
[TBL] [Abstract][Full Text] [Related]
14. Recognition and incision of gamma-radiation-induced cross-linked guanine-thymine tandem lesion G[8,5-Me]T by UvrABC nuclease.
Yang Z; Colis LC; Basu AK; Zou Y
Chem Res Toxicol; 2005 Sep; 18(9):1339-46. PubMed ID: 16167825
[TBL] [Abstract][Full Text] [Related]
15. Separation of mutation avoidance and antirecombination functions in an Escherichia coli mutS mutant.
Calmann MA; Nowosielska A; Marinus MG
Nucleic Acids Res; 2005; 33(4):1193-200. PubMed ID: 15731339
[TBL] [Abstract][Full Text] [Related]
16. MutS inhibits RecA-mediated strand exchange with platinated DNA substrates.
Calmann MA; Marinus MG
Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14174-9. PubMed ID: 15375217
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin adducts inhibit 1,N(6)-ethenoadenine repair by interacting with the human 3-methyladenine DNA glycosylase.
Kartalou M; Samson LD; Essigmann JM
Biochemistry; 2000 Jul; 39(27):8032-8. PubMed ID: 10891085
[TBL] [Abstract][Full Text] [Related]
18. HMG-domain protein recognition of cisplatin 1,2-intrastrand d(GpG) cross-links in purine-rich sequence contexts.
Cohen SM; Mikata Y; He Q; Lippard SJ
Biochemistry; 2000 Sep; 39(38):11771-6. PubMed ID: 10995245
[TBL] [Abstract][Full Text] [Related]
19. Recognition of DNA interstrand cross-links of cis-diamminedichloroplatinum(II) and its trans isomer by DNA-binding proteins.
Kaspárková J; Brabec V
Biochemistry; 1995 Sep; 34(38):12379-87. PubMed ID: 7547982
[TBL] [Abstract][Full Text] [Related]
20. Repair of cisplatin--DNA adducts by the mammalian excision nuclease.
Zamble DB; Mu D; Reardon JT; Sancar A; Lippard SJ
Biochemistry; 1996 Aug; 35(31):10004-13. PubMed ID: 8756462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
